References
Feero, W. G., Guttmacher, A. E., & Collins, F. S. (2008). The genome gets personal—almost. JAMA, 299, 1351-1352. doi: 10.1001/jama.299.11.1351
Hudson, K., Javitt, G., Burke, W., & Byers, P. (2007). ASHG statement on direct-to-consumer genetic testing in the United States. Obstetrics and Gynecology, 110, 1392-1395. doi: 10.1097/01.AOG.0000292086.98514.8b
Hunter, D. J., Khoury, M. J., & Drazen, J. M. (2008). Letting the genome out of the bottle—Will we get our wish? New England Journal of Medicine, 358, 105-107. doi: 10.1056/NEJMp0708162
Khoury, M. J., McBride, C., Schully, S. D., Ioannidis, J. P., Feero, W. G., Janssens, A. C., … Xu, J. (2009). The Scientific Foundation for personal genomics: Recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genetics in Medicine, 11, 559-567. doi: 10.1097/GIM.0b013e3181b13a6c
Manolio, T. A., Brooks, L. D., & Collins, F. S. (2008). A hapmap harvest of insights into the genetics of common diseases. Journal of Clinical Investigation, 118, 1590-1605. doi: 10.1172/JCI34772
McGuire, A. L., & Burke, W. (2008). An unwelcome side effect of direct-to-consumer personal genome testing: Raiding the medical commons. JAMA, 300, 2669-2671. doi: 10.1001/jama.2008.803
Robson, M. E., Storm, C. D., Weitzel, J., Wollins, D. S., & Offit, K. (2010). American Society of Clinical Oncology policy statement update: Genetic and genomic testing for cancer susceptibility. Journal of Clinical Oncology, 28, 893-901. doi: 10.1200/JCO.2009.27.0660